medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Número 6

Siguiente >>

Rev Invest Clin 2017; 69 (6)


Chikungunya: Molecular Aspects, Clinical Outcomes and Pathogenesis

Bautista-Reyes E, Núñez-Avellaneda D, Alonso-Palomares LA, Salazar MI

Idioma: Ingles.
Referencias bibliográficas: 72
Paginas: 299-307
Archivo PDF: 401.04 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kariuki M, Nderitu L, Ledermann JP, et al. Tracking epidemic chikungunya virus into the Indian Ocean from East Africa. J Gen Virol. 2008;89:2754-60.

  2. Schuffenecker I, Iteman I, Michault A, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3:e263.

  3. Gérardin P, Barau G, Michault A, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med. 2008;5:e60.

  4. Mavalankar D, Shastri P, Raman P. Chikungunya epidemic in India: a major public-health disaster. Lancet Infect Dis. 2007;7: 306-7.

  5. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, Lamballiere X. Chikungunya in the Americas. Lancet. 2014;383:514.

  6. Weaver SC. Arrival of Chikungunya virus in the New World: Prospects for spread and impact on public health. PLoS Negl Trop Dis. 2014;8:e2921.

  7. Morens D, Fauci AS. Chikungunya at the door - déjà vu all over again? N Engl J Med. 2014;371:885-7.

  8. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;2:e201.

  9. Kautz TF, Díaz-González EE, Erasmus JH, et al. Chikungunya virus as cause of febrile illness outbreak, Chiapas, Mexico, 2014. Emerg Infect Dis. 2015;21:2070-3.

  10. Díaz-González EE, Kautz TF, Dorantes-Delgado A, et al. First report of Aedes aegypti transmission of chikungunya virus in the Americas. Am J Trop Med Hyg. 2015;93:1325-9.

  11. Díaz-Quiñonez JA, Escobar-Escamilla N, Ortíz-Alcántara J, et al. Identification of Asian genotype of chikungunya virus isolated in Mexico. Virus Genes. 2016;52:127-9.

  12. Cigarroa-Toledo N, Blitvich BJ, Cetina-Trejo RC, et al. Chikungunya virus in febrile humans and Aedes aegypti mosquitoes, Yucatan, Mexico. Emerg Infect Dis. 2016;22:1804-7.

  13. Fernández-Salas I, Díaz-González EE, López-Gatell H, Alpuche-Aranda CM. Chikungunya and zika virus dissemination in the Americas: different arbovirus reflecting the same spreading routes and poor vector-control policies. Curr Opin Infect Dis. 2016;29: 467-75.

  14. Solignat M, Gay B, Higgs S, Briant L, Devaux C. Replication cycle of chikungunya: A re-emerging arbovirus. Virol J. 2009;393:183-97.

  15. Tsetsarkin KA, Chen R, Sherman MB, Weaver SC. Chikungunya virus: evolution and genetic determinants of emergence. Curr Opin Virol. 2011;1:310-7.

  16. Sumathy K, Ella KM. Genetic diversity of Chikungunya virus, India 2006-2010: Evolutionary dynamics and serotype analyses. J Med Virol. 2012;84:462-70.

  17. Schwartz O, Albert ML. Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol. 2010;8:491-500.

  18. Staples JE, Powers A, Tomashek K, et al. Preparación y respuesta ante la eventual introducción del virus chikungunya en las Américas. Washington, D.C. CDC/OPS (2011). ISBN: 978-92- 75-31632-0.

  19. Thiberville SD, Boisson V, Gaudart J, Simon F, Flahault A, Lamballerie X. Chikungunya fever: A clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl Trop Dis. 2013;7:e2004.

  20. Wintachai P, Wikan N, Kuadkitkan A, et al. Identification of prohibitin as a Chikungunya virus receptor protein. J Med Virol. 2012;84:1757-70.

  21. Kathiria AS, Burcher LD, Feagins LA, Souza RF, Boland R, Theiss AL. Phohibitin 1 modulates mitochondrial stress-related autophagy in human colonic epithelial cells. PLoS One. 2012;7:e31231.

  22. Powers AM, Logue CH. Changing patterns of chikungunya virus: Re-emergence of a zoonotic arbovirus. J Gen Virol. 2007;88: 2363-77.

  23. Lum FM, Teo TH, Lee WW, Kam YM, Rénia L, Ng LF. An essential role of antibodies in the control of chikungunya virus infection. J Immunol. 2013;190:6295-302.

  24. Simon F, Javelle E, Oliver M, Leparc-Goffart I, Marimoutou C. Chikungunya virus infection. Curr Infect Dis Rep. 2011;13:218-28.

  25. Thiberville S, Moyen N, Dupuis-Maguiraga L, et al. Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res. 2013;99:345-70.

  26. Gasque P, Couderc T, Lecuit M, Roques P, Ng LF. Chikungunya virus pathogenesis and immunity. Vector Borne Zoonotic Dis. 2015;15:241-9.

  27. Van Dujil-Richter MK, Horrnweg TE, Rodenhuis-Zybert IA, Smit JM. Early events in chikungunya virus infection-from virus cell binding to membrane fusion. Viruses. 2015;7:3647-74.

  28. Gérardin P, Fianu A, Michault A, et al. Predictors of chikungunya rheumatism: A prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther. 2013;15:R9.

  29. Burt FJ, Ralph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a re-emerging virus. Lancet 2012;379:662-71.

  30. Borgherini G, Poubeau P, Staikowsky F, et al. Outbreak of chikungunya on Réunion Island: Early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007;44:1401-7.

  31. Lakshmi V, Meeraja M, Sunnalaxmi MV, et al. Clinical features and molecular diagnosis of chikungunya fever from South India. Clin Infect Dis. 2008;46:1436-42.

  32. Mahendradas P, Avadhani K, Shetty R. Chikungunya and the eye: A review. J Ophthalmic Inflamm Infect. 2013;3:35.

  33. Lemant J, Boisson V, Winer A, et al. Serious acute chikungunya virus infection requiring intensive care during the Réunion Island outbreak in 2005-2006. Crit Care Med. 2008;36:2536-41.

  34. Economopoulou A, Dominguez M, Helynck B, et al. Atypical chikungunya virus infections: Clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol Infect. 2009;137:534-41.

  35. Valamparampil JJ, Chirakkarot S, Letha S, Jayakumar C, Gopinathan KM. Clinical profile of Chikungunya in infants. Indian J Pediatr. 2009;76:151-5.

  36. Nkoghe D, Kassa RF, Caron M, et al. Clinical forms of chikungunya in Gabon, 2010. PLoS Negl Trop Dis. 2012;6:e1517.

  37. Sebastian MR, Lodha R, Kabra SK. Chikungunya infection in children. Indian J Pediatr. 2009;76:185-9.

  38. Le Bomin A, Hebert JC, Marty P, Delaunay P. [Confirmed chikungunya in children in Mayotte. Description of 50 patients hospitalized from February to June 2006]. Med Trop (Mars). 2008;68: 491-5.

  39. Robin S, Ramful D, Le Seach F, Jaffar-Bandjee MC, Rigou G, Alessandri JL. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol. 2008;23:1028-35.

  40. Lewthwaite P, Vasanthapuram R, Osborne JC, et al. Chikungunya virus and central nervous system infections in children, India. Emerg Infect Dis. 2009;15:329-31.

  41. Simon F, Javelle E, Oliver M, Leparc-Goffart I, Marioutou C. Chikungunya infection: An emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore). 2007;86:123-37.

  42. Borgherini G, Poubeau P, Staikowsky F, et al. Persistent arthralgia associated with chikungunya virus: A study of 88 adult patients on Reunion island. Clin Infect Dis. 2008;47:469-75.

  43. Sissoko D, Malvy D, Ezzedine K, et al. Post-epidemic chikungunya disease on Reunion Island: Course of rheumatic manifestations and associated factors over a 15- month period. PLoS Negl Trop Dis. 2009;3:e389.

  44. Manimunda SP, Vijayachari P, Uppoor R, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Tran R Soc Trop Med Hyg. 2010;104:392-9.

  45. Schilte C, Staikovsky F, Couderc T, et al. Chikungunya virusassociated long-term arthralgia: A 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7:e2137.

  46. Waymouth HE, Zoutman DE, Towheed TE. Chikungunya-related arthritis: Case report and review of the literature. Semin Arthritis Rheum. 2013;43:273-8.

  47. Chopra A, Anuradha V, Ghorpade R, Saluja M. Acute chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: A 2-year prospective rural community study. Epidemiol Infect. 2012;140:842-50.

  48. Moro ML, Grilli E, Corvetta A, et al. Long-term chikungunya infection clinical manifestations after an outbreak in Italy: A prognostic cohort study. J Infect. 2012;65:165-72.

  49. Mohd-Zim MA, Sam IC, Syed-Omar SF, Chan YF, AbuBakar S, Kamarulzaman A. Chikungunya infection in Malaysia: Comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol. 2013;56:141-5.

  50. Malvy D, Ezzedine K, Mamani-Matsuda M, et al. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis. 2009;9:200.

  51. Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following chikungunya fever. A mean follow-up of two years. Joint Bone Spine. 2009;76:654-7.

  52. Marimoutou C, Vivier E, Oliver M, Boutin JP, Simon F. Morbidity and impaired quality of life 30 months after chikungunya infection: Comparative cohort of infected and uninfected French military policemen in Réunion Island. Medicine (Baltimore). 2012;91: 212-19.

  53. Couturier E, Guillemin F, Mura M, et al. Impaired quality of life after chikungunya virus infection: A 2-year follow-up study. Rheumatology (Oxford). 2012;51:1315-22.

  54. Hoarau JJ, Jaffar-Bandjee MC, Krejbich-Trotot P, et al. Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol. 2010;184:5914-27.

  55. Kam Y, Simarmata D, Chow A, et al. Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis. 2012;205:1147-54.

  56. Shenoy S, Pradeep GC. Neurodevelopmental outcome of neonates with vertically transmitted chikungunya fever with encephalopathy. Indian Pediatr. 2012;49:238-40.

  57. Ramful D, Sampériz S, Fritel X, et al. Antibody kinetics in infants exposed to chikungunya virus infection during pregnancy reveals absence of congenital infection. J Infect Dis. 2014;209:1726-30.

  58. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol. 1998;52:943-51.

  59. Walsh NC, Reinwald S, Manning CA, et al. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res. 2009;24:1572-85.

  60. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis. Nature. 1999;397:315-23.

  61. Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999;13: 2412-24.

  62. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309-19.

  63. Horwood NJ, Elliot J, Martin TJ, Gillespie MT. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology. 1998;139:4743-6.

  64. Chopra A, Anuradha V, Lagoo-Joshin V, Kunjir V, Salvi S, Saluja M. Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum. 2008;58:2921-2.

  65. Phuklia W, Kasisith J, Modhiran N, et al. Osteoclastogenesis induced by CHIKV- infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/arthritis. Virus Res. 2013; 177:179-88.

  66. Chen W, Foo S-S, Sims NA, Herrero LJ, Walsh NC, Mahalingam S. Arthritogenic alphavirus: new insights into arthritis and bone pathology. Micro. 2015;234:35-43.

  67. Chow A, Zhishenng H, Ong EK, et al. Persistent arthralgia induced by chikungunya virus infection is associated with interleukin- 6 and granulocyte macrophage colony stimulating factor. J Infect Dis. 2011;203:149-57.

  68. Ng LF, Chow A, Sun Y-J, et al. IL-1beta, IL-6, and RANTES as biomarkers of chikungunya severity. PLoS One. 2009;4:e4261.

  69. Noret M, Herrero L, Rulli N, et al. Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts. J Infect Dis. 2012;206:455-7.

  70. Lindbury BA, Rulli NE, Suhrbier A, et al. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis. 2008;197:1585-93.

  71. Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiquino A, Leroy EM. The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis. 2011;204:115-23.

  72. Teo TH, Lum FM, Claser C, et al. A pathogenic role for CD4+ T cells during chikungunya virus infection in mice. J Immunol. 2013;190:259-69.




2020     |     www.medigraphic.com